Giardina J B, Tanner D J, Khalil R A
Department of Physiology and Biophysics and Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, USA.
Hypertension. 2001 Feb;37(2 Pt 2):561-8. doi: 10.1161/01.hyp.37.2.561.
Oxidized low-density lipoprotein (ox-LDL) plays a critical role in the development of atherosclerotic coronary vasospasm; however, the cellular mechanisms involved are not fully understood. We tested the hypothesis that ox-LDL enhances coronary vasoconstriction by increasing the activity of specific protein kinase C (PKC) isoforms in coronary smooth muscle. Active stress was measured in de-endothelialized porcine coronary artery strips; cell contraction and Ca(2+) were monitored in single coronary smooth muscle cells loaded with fura-2; and the cytosolic and particulate fractions were examined for PKC activity and reactivity with isoform-specific anti-PKC antibodies with Western blots. Ox-LDL (100 microgram/mL) caused slow but significant increases in active stress to 1.3+/-0.4x10(3) N/m(2) and cell contraction (10%) that were completely inhibited by GF109203X (10(-6) mol/L), an inhibitor of Ca(2+)-dependent and -independent PKC isoforms, with no significant change in Ca(2+). 5-Hydroxytryptamine (5-HT; 10(-7) mol/L) and KCl (24 mmol/L) caused increases in cell contraction and Ca(2+) that were inhibited by the Ca(2+) channel blocker verapamil (10(-6) mol/L). Ox-LDL enhanced coronary contraction to 5-HT and KCl with no additional increases in Ca(2+). Direct activation of PKC by phorbol 12-myristate13-acetate (PMA; 10(-7) mol/L) caused a contraction similar in magnitude and time course to ox-LDL-induced contraction and enhanced 5-HT- and KCl-induced contraction with no additional increases in Ca(2+). The ox-LDL-induced enhancement of 5-HT and KCl contraction was inhibited by Gö6976 (10(-6) mol/L), an inhibitor of Ca(2+)-dependent PKC isoforms. Both ox-LDL and PMA caused an increase in PKC activity in the particulate fraction, a decrease in the cytosolic fraction, and an increase in the particulate/cytosolic PKC activity ratio. Western blots revealed the Ca(2+)-dependent PKC-alpha and the Ca(2+)-independent PKC-delta, -epsilon, and -zeta isoforms. In unstimulated tissues, PKC-alpha- and -epsilon were mainly cytosolic, PKC-delta was mainly in the particulate fraction, and PKC-zeta was equally distributed in the cytosolic and particulate fractions. Ox-LDL alone or PMA alone caused translocation of PKC-epsilon from the cytosolic to particulate fraction, whereas the distribution pattern of PKC-alpha, -delta, and -zeta remained unchanged. 5-HT (10(-7) mol/L) alone and KCl alone did not change PKC activity. In tissues pretreated with ox-LDL or PMA, 5-HT and KCl caused additional increases in PKC-alpha activity. Native LDL did not significantly affect coronary contraction, Ca(2+), or PKC activity. These results suggest that ox-LDL causes coronary contraction via activation of the Ca(2+)-independent PKC-epsilon and enhances the contraction to Ca(2+)-increasing agonists by activating the Ca(2+)-dependent PKC-alpha. Activation of PKC-alpha and -epsilon may represent a possible cellular mechanism by which ox-LDL could enhance coronary vasospasm.
氧化型低密度脂蛋白(ox-LDL)在动脉粥样硬化性冠状动脉痉挛的发生发展中起关键作用;然而,其中涉及的细胞机制尚未完全明确。我们检验了这样一个假说,即ox-LDL通过增加冠状动脉平滑肌中特定蛋白激酶C(PKC)同工型的活性来增强冠状动脉收缩。在去内皮的猪冠状动脉条上测量主动张力;在负载fura-2的单个冠状动脉平滑肌细胞中监测细胞收缩和Ca(2+);通过蛋白质免疫印迹法检测胞质和微粒体部分的PKC活性以及与同工型特异性抗PKC抗体的反应性。ox-LDL(100微克/毫升)使主动张力缓慢但显著增加至1.3±0.4x10(3) N/m(2),细胞收缩增加(10%),这被GF109203X(10(-6)摩尔/升)完全抑制,GF109203X是一种钙依赖性和非依赖性PKC同工型的抑制剂,Ca(2+)无显著变化。5-羟色胺(5-HT;10(-7)摩尔/升)和氯化钾(24毫摩尔/升)使细胞收缩和Ca(2+)增加,这被钙通道阻滞剂维拉帕米(10(-6)摩尔/升)抑制。ox-LDL增强了对5-HT和氯化钾的冠状动脉收缩,而Ca(2+)没有进一步增加。佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA;10(-7)摩尔/升)直接激活PKC引起的收缩在幅度和时间进程上与ox-LDL诱导的收缩相似,并增强了5-HT和氯化钾诱导的收缩,而Ca(2+)没有进一步增加。ox-LDL诱导的对5-HT和氯化钾收缩的增强被Gö6976(10(-6)摩尔/升)抑制,Gö6976是一种钙依赖性PKC同工型的抑制剂。ox-LDL和PMA均导致微粒体部分PKC活性增加,胞质部分PKC活性降低,微粒体/胞质PKC活性比值增加。蛋白质免疫印迹法显示了钙依赖性PKC-α和非钙依赖性PKC-δ、-ε和-ζ同工型。在未受刺激的组织中,PKC-α和-ε主要位于胞质中,PKC-δ主要位于微粒体部分,PKC-ζ在胞质和微粒体部分中分布均匀。单独的ox-LDL或单独的PMA导致PKC-ε从胞质转位至微粒体部分,而PKC-α、-δ和-ζ的分布模式保持不变。单独的5-HT(10(-7)摩尔/升)和单独的氯化钾不改变PKC活性。在用ox-LDL或PMA预处理的组织中,5-HT和氯化钾使PKC-α活性进一步增加。天然LDL对冠状动脉收缩、Ca(2+)或PKC活性无显著影响。这些结果表明,ox-LDL通过激活非钙依赖性PKC-ε引起冠状动脉收缩,并通过激活钙依赖性PKC-α增强对Ca(2+)增加的激动剂的收缩。PKC-α和-ε的激活可能代表ox-LDL增强冠状动脉痉挛的一种可能的细胞机制。